Top compounds associated with response to SDHA


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.01
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.086 0.01
mRNA PD318088 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.01
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA BHG712 GDSC1000 pan-cancer AAC -0.073 0.01
mRNA foretinib GDSC1000 pan-cancer AAC -0.078 0.02
mRNA regorafenib CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC -0.18 0.02
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.088 0.02
Download CSV